12:00 AM
 | 
Jul 30, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Pain Therapeutics Inc. preclinical data

In a mouse model of AD and in brain tissue from deceased AD patients, PTI-125 suppressed the toxic effects of beta...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >